Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2020 | 04-2020 | 01-2020 | 10-2019 | 07-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 561 | 0 | 6 | 31 | 9 |
| Receivables | 8 | 6 | 5 | 4 | 10 |
| Inventories | N/A | N/A | N/A | 0 | 47 |
| Other current assets | 0 | 0 | 0 | 0 | 5 |
| TOTAL | $568 | $6 | $11 | $40 | $71 |
| Non-Current Assets | |||||
| Intangibles | 1,238 | 1,238 | N/A | N/A | N/A |
| TOTAL | $1,238 | $1,238 | $0 | $0 | $0 |
| Total Assets | $1,806 | $1,244 | $11 | $40 | $71 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 70 | 50 | 41 | 21 | N/A |
| Accounts payable and accrued liabilities | 7 | 7 | 7 | 52 | 88 |
| Accrued Expenses | 73 | 76 | 43 | 10 | 24 |
| Other current liabilities | 0 | 0 | N/A | N/A | 10 |
| TOTAL | $175 | $245 | $91 | $82 | $124 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 337 | 338 | 0 | 0 | 0 |
| TOTAL | $337 | $338 | $0 | $0 | $0 |
| Total Liabilities | $512 | $583 | $91 | $82 | $124 |
| Shareholders' Equity | |||||
| Common Shares | 5,684 | 4,980 | 4,192 | 4,192 | 4,192 |
| Retained earnings | -4,446 | -4,374 | -4,328 | -4,290 | -4,301 |
| Other shareholders' equity | 56 | 56 | 56 | 56 | 56 |
| TOTAL | $1,294 | $661 | $-80 | $-42 | $-53 |
| Total Liabilities And Equity | $1,806 | $1,244 | $11 | $40 | $71 |